Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation

Philip G. Kasprzyk, Frank Cuttitta, Ingalill Avis, Yoichi Nakanishi, Anthony Treston, Helen Wong, John H. Walsh, James L. Mulshine

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

A solid-phase radioimmunoassay utilizing iodinated peptide-specific monoclonal antibody as a detection system instead of labeled peptide has been developed. Regional specific monoclonal antibodies to either gastrin-releasing peptide or gastrin were used as models to validate the general application of our modified assay. Conditions for radioactive labeling of the monoclonal antibody were determined to minimize oxidant damage, which compromises the sensitivity of other reported peptide quantitation assays. Pretreatment of 96-well polyvinyl chloride test plates with a 5% glutaraldehyde solution resulted in consistent retention of sufficient target peptide on the solid-phase matrix to allow precise quantitation. This quantitative method is completed within 1 h of peptide solid phasing. Pretreatment of assay plates with glutaraldehyde increased binding of target peptide and maximized antibody binding by optimizing antigen presentation. The hypothesis that glutaraldehyde affects both peptide binding to the plate and orientation of the peptide was confirmed by analysis of several peptide analogs. These studies indicate that peptide binding was mediated through a free amino group leaving the carboxy-terminal portion of the target peptide accessible for antibody binding. It was observed that the length of the peptide also affects the amount of monoclonal antibody that will bind. Under the optimal conditions, results from quantitation of gastrin-releasing peptide in relevant samples agree well with those from previously reported techniques. Thus, we report here a modified microplate assay which may be generally applied for the rapid and sensitive quantitation of peptide hormones.

Original languageEnglish
Pages (from-to)224-234
Number of pages11
JournalAnalytical Biochemistry
Volume174
Issue number1
DOIs
Publication statusPublished - Jan 1 1988
Externally publishedYes

Fingerprint

Glutaral
Assays
Monoclonal Antibodies
Peptides
Gastrin-Releasing Peptide
Peptide Hormones
Antibodies
Gastrins
Antigen Presentation
Polyvinyl Chloride
Oxidants
Labeling
Radioimmunoassay
Antigens

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Kasprzyk, P. G., Cuttitta, F., Avis, I., Nakanishi, Y., Treston, A., Wong, H., ... Mulshine, J. L. (1988). Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation. Analytical Biochemistry, 174(1), 224-234. https://doi.org/10.1016/0003-2697(88)90539-8

Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation. / Kasprzyk, Philip G.; Cuttitta, Frank; Avis, Ingalill; Nakanishi, Yoichi; Treston, Anthony; Wong, Helen; Walsh, John H.; Mulshine, James L.

In: Analytical Biochemistry, Vol. 174, No. 1, 01.01.1988, p. 224-234.

Research output: Contribution to journalArticle

Kasprzyk, PG, Cuttitta, F, Avis, I, Nakanishi, Y, Treston, A, Wong, H, Walsh, JH & Mulshine, JL 1988, 'Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation', Analytical Biochemistry, vol. 174, no. 1, pp. 224-234. https://doi.org/10.1016/0003-2697(88)90539-8
Kasprzyk, Philip G. ; Cuttitta, Frank ; Avis, Ingalill ; Nakanishi, Yoichi ; Treston, Anthony ; Wong, Helen ; Walsh, John H. ; Mulshine, James L. / Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation. In: Analytical Biochemistry. 1988 ; Vol. 174, No. 1. pp. 224-234.
@article{b56ca3277f954ca58556feb1cb3eb61e,
title = "Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation",
abstract = "A solid-phase radioimmunoassay utilizing iodinated peptide-specific monoclonal antibody as a detection system instead of labeled peptide has been developed. Regional specific monoclonal antibodies to either gastrin-releasing peptide or gastrin were used as models to validate the general application of our modified assay. Conditions for radioactive labeling of the monoclonal antibody were determined to minimize oxidant damage, which compromises the sensitivity of other reported peptide quantitation assays. Pretreatment of 96-well polyvinyl chloride test plates with a 5{\%} glutaraldehyde solution resulted in consistent retention of sufficient target peptide on the solid-phase matrix to allow precise quantitation. This quantitative method is completed within 1 h of peptide solid phasing. Pretreatment of assay plates with glutaraldehyde increased binding of target peptide and maximized antibody binding by optimizing antigen presentation. The hypothesis that glutaraldehyde affects both peptide binding to the plate and orientation of the peptide was confirmed by analysis of several peptide analogs. These studies indicate that peptide binding was mediated through a free amino group leaving the carboxy-terminal portion of the target peptide accessible for antibody binding. It was observed that the length of the peptide also affects the amount of monoclonal antibody that will bind. Under the optimal conditions, results from quantitation of gastrin-releasing peptide in relevant samples agree well with those from previously reported techniques. Thus, we report here a modified microplate assay which may be generally applied for the rapid and sensitive quantitation of peptide hormones.",
author = "Kasprzyk, {Philip G.} and Frank Cuttitta and Ingalill Avis and Yoichi Nakanishi and Anthony Treston and Helen Wong and Walsh, {John H.} and Mulshine, {James L.}",
year = "1988",
month = "1",
day = "1",
doi = "10.1016/0003-2697(88)90539-8",
language = "English",
volume = "174",
pages = "224--234",
journal = "Analytical Biochemistry",
issn = "0003-2697",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation

AU - Kasprzyk, Philip G.

AU - Cuttitta, Frank

AU - Avis, Ingalill

AU - Nakanishi, Yoichi

AU - Treston, Anthony

AU - Wong, Helen

AU - Walsh, John H.

AU - Mulshine, James L.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - A solid-phase radioimmunoassay utilizing iodinated peptide-specific monoclonal antibody as a detection system instead of labeled peptide has been developed. Regional specific monoclonal antibodies to either gastrin-releasing peptide or gastrin were used as models to validate the general application of our modified assay. Conditions for radioactive labeling of the monoclonal antibody were determined to minimize oxidant damage, which compromises the sensitivity of other reported peptide quantitation assays. Pretreatment of 96-well polyvinyl chloride test plates with a 5% glutaraldehyde solution resulted in consistent retention of sufficient target peptide on the solid-phase matrix to allow precise quantitation. This quantitative method is completed within 1 h of peptide solid phasing. Pretreatment of assay plates with glutaraldehyde increased binding of target peptide and maximized antibody binding by optimizing antigen presentation. The hypothesis that glutaraldehyde affects both peptide binding to the plate and orientation of the peptide was confirmed by analysis of several peptide analogs. These studies indicate that peptide binding was mediated through a free amino group leaving the carboxy-terminal portion of the target peptide accessible for antibody binding. It was observed that the length of the peptide also affects the amount of monoclonal antibody that will bind. Under the optimal conditions, results from quantitation of gastrin-releasing peptide in relevant samples agree well with those from previously reported techniques. Thus, we report here a modified microplate assay which may be generally applied for the rapid and sensitive quantitation of peptide hormones.

AB - A solid-phase radioimmunoassay utilizing iodinated peptide-specific monoclonal antibody as a detection system instead of labeled peptide has been developed. Regional specific monoclonal antibodies to either gastrin-releasing peptide or gastrin were used as models to validate the general application of our modified assay. Conditions for radioactive labeling of the monoclonal antibody were determined to minimize oxidant damage, which compromises the sensitivity of other reported peptide quantitation assays. Pretreatment of 96-well polyvinyl chloride test plates with a 5% glutaraldehyde solution resulted in consistent retention of sufficient target peptide on the solid-phase matrix to allow precise quantitation. This quantitative method is completed within 1 h of peptide solid phasing. Pretreatment of assay plates with glutaraldehyde increased binding of target peptide and maximized antibody binding by optimizing antigen presentation. The hypothesis that glutaraldehyde affects both peptide binding to the plate and orientation of the peptide was confirmed by analysis of several peptide analogs. These studies indicate that peptide binding was mediated through a free amino group leaving the carboxy-terminal portion of the target peptide accessible for antibody binding. It was observed that the length of the peptide also affects the amount of monoclonal antibody that will bind. Under the optimal conditions, results from quantitation of gastrin-releasing peptide in relevant samples agree well with those from previously reported techniques. Thus, we report here a modified microplate assay which may be generally applied for the rapid and sensitive quantitation of peptide hormones.

UR - http://www.scopus.com/inward/record.url?scp=0023771294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023771294&partnerID=8YFLogxK

U2 - 10.1016/0003-2697(88)90539-8

DO - 10.1016/0003-2697(88)90539-8

M3 - Article

C2 - 3146232

AN - SCOPUS:0023771294

VL - 174

SP - 224

EP - 234

JO - Analytical Biochemistry

JF - Analytical Biochemistry

SN - 0003-2697

IS - 1

ER -